CDF
CDF chair: more treatment reviews to come
January 16, 2015Sales and Marketing CDF, Cancer Drugs Fund, NHS, NHS England, NICE, peter clark
The chair of NHS England’s cancer drugs fund has said there is likely to be more reviews of affordable treatments …
NHS drops 25 treatments from Cancer Drugs Fund
January 12, 2015Sales and Marketing Afinitor, CDF, Cancer, Cancer Drugs Fund, Eisa, Halaven, Heribulin, Jevtana, NHS, Sanofi, Zaltrap, aflibercept, cabazitaxel, everolimus
Twenty-five cancer treatments will be removed from the Cancer Drugs Fund list, NHS England has announced. Having concluded its review …
AstraZeneca drops CDF application
January 12, 2015Sales and Marketing AstraZeneca, CDF, Cancer, NHS, NICE, lynparza, olaparib
AstraZeneca has withdrawn its application for its drug Lynparza to be on the Cancer Drugs Fund (CDF), citing concerns with …
Celgene UK: market access is a complex business
December 15, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abraxane, CDF, Cancer, Celgene, PPRS, Revlimid, market access, sam pierce
Being a firm that specialises in cancer drugs, Celgene UK is no stranger to England’s notoriously rigorous approach to expensive …
Labour to extend cancer drugs funding if elected
December 10, 2014Research and Development, Sales and Marketing CDF, Cancer, Labour, NHS, NICE, andy burnham, election
Labour has committed to continuing the Cancer Drugs Fund system under the guise of a new £330 million ‘Cancer Treatment …
Astellas ‘app challenge’ aims to inspire future talent
December 4, 2014Medical Communications, Sales and Marketing Astellas, CDF, CRUK, Ken Jones, app, my jar, stem
Last week Astellas announced the winner of its Science, Technology, Engineering, and Mathematics (STEM) skills Innovation Challenge competition at an …
Charity ‘deeply concerned’ on CDF changes
November 13, 2014Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, breakthrough breast cancer, palframan
A leading cancer charity has warned that a number of key drugs are at risk of being withdrawn from patients …
Wales Assembly facing questions over cancer
November 5, 2014Research and Development, Sales and Marketing CDF, Cancer, NHS, Wales, Welsh, assembly, drugs fund, oncology
The state of cancer services in Wales has come under increased scrutiny this week as the country’s ability to provide …
Public opinion divided over UK drugs spend
October 7, 2014Medical Communications, Research and Development, Sales and Marketing ABPI, CDF, NHS, NICE, PPRS, UK, coalition, drugs spending, government
A new survey conducted for the ABPI shows that public opinion on whether the UK spends enough money on medicines …
NHS England consults on Cancer Drugs Fund
October 6, 2014Research and Development, Sales and Marketing CDF, Cancer, NHS, NHS England, commissioning, oncology
NHS England is declaring new changes to the way the Cancer Drugs Fund operates in order to plug a major …
NICE: Cancer Drugs Fund must use our processes
September 3, 2014Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, David Haslam, Kadcyla, NICE, Roche
NICE believes that the Cancer Drugs Fund should be aligned with its cost-effectiveness processes, after the government recently announced a …
NICE rejects Kadcyla
April 23, 2014Sales and Marketing CDF, Cancer, Genentech, Kadcyla, NHS, NICE, Roche
NICE has delivered a severe blow to Roche by rejecting its breast cancer ‘smart bomb’ Kadcyla for NHS use in …
NICE says ‘no’ to Xofigo
March 24, 2014Sales and Marketing Bayer, CDF, NHS, NICE, abiraterone, prostate, xofigo
NICE has dealt Bayer a severe blow by not approving prostate cancer drug Xofigo for use on the NHS in …
A treatment room view
February 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, Roche, avastin, hinsely
A little more than a year ago, Lisa Hinsley’s prospects were not good. The mother of three had been diagnosed …
Kadcyla launches in UK
February 13, 2014Sales and Marketing CDF, Cancer, Kadcyla, NHS, Roche, breast
Roche’s Kadcyla, indicated to treat an aggressive form of breast cancer, has launched today in the UK.Kadcyla (trastuzumab emtansine) which …
Latest content
Five Facts about cardiovascular disease
